Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karen L. Smith Insider Profile
4 Followers
Karen L. Smith, EVP, R&D and CMO at Jazz Pharmaceuticals, holds 28.47K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds ― shares in Sucampo Pharmaceuticals (Ticker: SCMP), holds 52.10K shares in Sangamo Biosciences (Ticker: SGMO).
Karen L. Smith has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Karen L. Smith holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Karen L. Smith
Karen L. Smith's Trading History
Jazz Pharmaceuticals
Mar 07, 2018
EVP, R&D and CMO
Uninformative Sell
92.92K
$3.10M
Sucampo Pharmaceuticals
―
―
―
―
Acceleron Pharma
Nov 22, 2021
―
Uninformative Sell
―
$0.00
Sangamo Biosciences
Jun 05, 2023
Director
Uninformative Buy
―
$26.57K
Antares Pharma
Jun 14, 2021
―
Uninformative Buy
112.50K
$445.22K
Emergent Biosolutions
May 11, 2021
EVP, Chief Medical Officer
Uninformative Sell
18.56K
$25.68K
Tourmaline Bio
―
Director
―
―
Quince Therapeutics
May 23, 2022
CMO
Uninformative Buy
―
$25.80K
Aurinia Pharmaceuticals
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Karen L. Smith's performance on stock
You May Also Like
Karen L. Smith insider profile FAQ
What is the percentage of profitable transactions made by Karen L. Smith?
The percentage of profitable transactions made by Karen L. Smith is ―.
What is the average return per transaction made by Karen L. Smith?
The average return per transaction made by Karen L. Smith is ―.
What stocks does Karen L. Smith hold?
Karen L. Smith holds: JAZZ, SCMP, XLRN, SGMO, ATRS, EBS, TRML, QNCX, AUPH stocks.
What was Karen L. Smith’s latest transaction?
Karen L. Smith latest transaction was an Uninformative Sell of $92.92K.
What was Karen L. Smith's most profitable transaction?
Karen L. Smith’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Karen L. Smith's role in Jazz Pharmaceuticals?
Karen L. Smith's role in Jazz Pharmaceuticals is EVP, R&D and CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.